Healthpeak Properties, Inc. (DOC) gains on deep earnings analysis
Healthpeak Properties, Inc. (DOC) gained despite an earnings miss, as revenue beat estimates and operating trends improved across senior housing, lab, and outpatient medical assets. This deep-dive analysis looks beyond the headline to assess occupancy gains, leasing momentum, raised FFO guidance, and what the mixed print means for DOC shares.
Healthpeak Properties, Inc. (NYSE: DOC) rose after earnings even though EPS missed estimates, because revenue beat expectations and management lifted adjusted FFO guidance. Investors are focusing on improving occupancy, stronger senior housing NOI, and a solid balance sheet that supports the longer-term turnaround story.
Healthpeak Properties, Inc. (DOC) Gains After Earnings Miss
Healthpeak Properties, Inc. (DOC) shares posted gains of 2.36% to $19.48 at the latest regular-session close, despite an earnings miss. The company reported EPS of $0.02 against $0.06355 expected, while revenue of $0.82B beat the $0.74B estimate. That split puts the DOC earnings story between weak bottom-line conversion and improving property operations.
Key Takeaways
EPS missed expectations at $0.02 versus $0.06355, while revenue beat estimates at $0.82B versus $0.74B.
EPS fell from $0.08 in the prior quarter and $0.28 in March, but remained above the $0.17 loss reported in the year-ago quarter.
Senior Housing delivered the strongest operating update, with 260 basis points of same-store occupancy growth and 19% NOI growth.
Lab occupancy increased 80 basis points sequentially to 78.5%, while outpatient medical occupancy rose 20 basis points to 90.7%.
Healthpeak raised its adjusted FFO guidance range by $0.02 to $1.73 to $1.77 per share.
The analyst consensus remains Hold, with 19 Buy ratings, 22 Hold ratings, and no Sell or Strong Sell ratings.
Financial Performance: Revenue Beat, EPS Pressure
The central fact in this Healthpeak Properties, Inc. earnings analysis is the gap between revenue and EPS. Revenue reached $0.82B, beating the $0.74B estimate. The prior quarterly revenue figures were $0.77B in June, $0.75B in March, $0.72B in December, and $0.71B in the year-ago quarter. The latest result therefore extended a steady top-line climb.
EPS told a different story. The $0.02 result trailed the $0.08 reported in June and the $0.28 posted in March. It did improve on the $0.16 result from December and the $0.17 loss from the year-ago quarter. Investors therefore received revenue growth without matching earnings momentum, a combination that often creates a more demanding test for management's operating narrative.
Segment operating data gives that narrative some support. Outpatient Medical Buildings produced 1.2 million square feet of leasing activity, including about 327,000 square feet of new leases. Tenant retention reached 80%, and cash re-leasing spreads were 5%. Total occupancy rose 20 basis points to 90.7%.
Lab also moved in the right direction, although from a lower occupancy base. Healthpeak executed 381,000 square feet of leases, with 60% classified as new leasing and 30% involving vacant space. Occupancy increased 80 basis points to 78.5%, up 140 basis points from year-end 2025. The Torrey Pines portfolio reached a 97% leased percentage when executed leases and letters of intent were included, compared with about 65% at year-end 2025.
Senior Housing supplied the strongest growth figures in the operating update. The same-store portfolio recorded 260 basis points of occupancy growth and 19% NOI growth. Janus Living also reported 45% total revenue growth and 34% adjusted EBITDA growth, while Healthpeak's ownership interest reached 74%.
The balance sheet remains a counterweight to the soft EPS result. Net debt to adjusted EBITDA stood at 4.7x, available liquidity reached $4.1B, and Healthpeak had repaid $900M of debt through August 4, including $650M of senior unsecured notes in July. The company also reported adjusted FFO of $0.46 per share in its operating update.
Get AI research on any stock
Instant reports, daily intelligence, and an AI analyst in your pocket.
DOC shares rose 2.36% to $19.48 at the latest regular-session close. Trading volume reached 9,581,700 shares against an average of 5,390,218. The price response was positive even though EPS missed, which points to investors giving weight to the $0.82B revenue beat, the raised FFO range, and stronger occupancy trends.
The analyst consensus remains Hold. The tally includes 19 Buy ratings and 22 Hold ratings, with no Sell, Strong Buy, or Strong Sell ratings. That distribution reflects a balanced view: Healthpeak has visible operating progress, but the latest $0.02 EPS result does not yet confirm a broad earnings acceleration.
The market's response also separates company quality from near-term stock performance. A stronger balance sheet and better leasing metrics can improve the long-term investment case, while the weak EPS figure keeps pressure on management to convert property-level gains into per-share growth.
CEO Scott Brinker framed Healthpeak as a more active operator after several years of pressure in life science real estate. He pointed to the company's $5B merger, $1B IPO, internal property management capabilities, and joint ventures with Blackstone and Brookfield. His main strategic shift is away from development alone and toward acquiring life science assets as pricing and capital conditions improve.
Life science has been a development game for the past decade, but for the next few years, it will be an acquisition game, and we have the platform and balance sheet to capitalize on the opportunity. - Scott Brinker, CEO, Earnings Call
That strategy rests on financial flexibility. Brinker said leverage was below 5x and described stock buybacks as less attractive at the current price than they were in April, when Healthpeak bought $100M of stock below $17 per share at a 10-plus percent FFO yield.
CFO Kelvin Moses supplied the numbers behind the outlook. Healthpeak expects $1.9B of gross proceeds from capital recycling initiatives through year-end. The company has also completed $1B of acquisitions and buybacks, giving management room to balance debt reduction, acquisitions, development, and repurchases.
We raised our FFO's adjusted guidance range by $0.02 to $1.73 to $1.77 per share. - Kelvin Moses, CFO, Earnings Call
Moses tied the guidance increase to a 75 basis point increase in total same-store NOI from the midpoint. Lab and Senior Housing each received 200 basis point increases at the midpoint, while the company also recognized lower market interest amortization tied to a $400M seller note repayment.
Analyst Q&A Highlights
The Q&A focused on whether improving occupancy can become sustained same-store NOI growth, especially in Lab. Morgan Stanley analyst Ronald Kamdem pressed management for a timeline.
When do you think you'll have line of sight to be able to see sort of same-store inflect to the positive? - Ronald Kamdem, Morgan Stanley, Earnings Call
We started with 77% occupancy coming into the year and now we're at 78.5% total occupancy. - Kelvin Moses, CFO, Earnings Call
Moses defended the leasing progress but stopped short of naming a specific quarter for positive same-store inflection. Brinker then shifted the focus from same-store statistics to total occupancy and total NOI, arguing that growing the occupied asset base matters more for earnings growth.
BMO Capital Markets analyst Juan Sanabria challenged management on competition and lease economics, including free rent, tenant improvement costs, and tenant size.
Just curious if anything has changed with regards to the rate environment, free rent, build-out costs, et cetera? - Juan Sanabria, BMO Capital Markets, Earnings Call
The pipeline continues to be fairly robust. We've had a 2 million square foot leasing pipeline. - Kelvin Moses, CFO, Earnings Call
Moses centered the answer on demand rather than concessions. He said the pipeline included about 500,000 square feet under letters of intent and remained disproportionately weighted toward wet lab space. That answer reinforces Healthpeak's volume-first approach: capture demand, fill vacant space, and allow higher occupancy to drive NOI.
Bottom Line
DOC delivered a revenue beat, stronger leasing data, and higher FFO guidance, but the $0.02 EPS result remains the central weakness. Healthpeak's balance sheet and occupancy gains support a recovery thesis, while investors still need better per-share earnings conversion before the Hold consensus can shift toward broader conviction.
+Why did Healthpeak Properties (DOC) stock go up after missing earnings?
Healthpeak Properties reported EPS of $0.02 versus the $0.06355 estimate, but revenue came in at $0.82 billion versus the $0.74 billion consensus. Investors also reacted positively to raised adjusted FFO guidance and improving occupancy trends across its core property segments.
+What were Healthpeak Properties' latest earnings results?
Healthpeak Properties posted EPS of $0.02, below the expected $0.06355, while revenue reached $0.82 billion and beat the $0.74 billion estimate. The company also reported adjusted FFO of $0.46 per share in its operating update.
+Did Healthpeak Properties raise guidance after earnings?
Yes, Healthpeak raised its adjusted FFO guidance range by $0.02 to $1.73 to $1.77 per share. That increase helped offset the weaker-than-expected EPS result and supported the stock's positive reaction.
+What operating trends are improving at Healthpeak Properties (DOC)?
Senior Housing posted 260 basis points of same-store occupancy growth and 19% NOI growth, while lab occupancy rose 80 basis points sequentially to 78.5%. Outpatient medical occupancy also increased 20 basis points to 90.7%, showing broad improvement across the portfolio.
▌The Daily Briefing · Free
A new stock idea, every evening.
One stock worth watching each weekday, plus the analysis behind it. Free, in your inbox.
▌The Full Report
Want the full picture on DOC?
The analyst-grade research report — charts, grades, valuation, and price targets — in 10 minutes.
